Mosanna Therapeutics
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
1
Funding Rounds
$80.0m
Money raised
Overview
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
- Website:
- Business model: B2C
- Headquarters: Basel
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Mosanna Therapeutics has raised a total of $80m in funding over 1 rounds.
Key Insights:
- Mosanna Therapeutics Series A Round, June 2025: $80m
Mosanna Therapeutics Series A Round, June 2025
$80m
Industries
Mosanna Therapeutics is active in the following industries: